Scientists in Edinburgh are using engineered bacteria to turn everyday plastic waste into a vital drug for Parkinson’s disease.
Imagine a world where the plastic bottle you throw in the recycling can one day heal your brain. Scientists in University of Edinburgh they apply this idea to life. Their ground-breaking research shows that discarded PET bottles, which we see in beverage and food packaging, can be turned into L-DOPA, a leading drug to treat the symptoms of Parkinson’s disease (1).
Magic happens with special design E coli bacteria. These small biological factories can digest the plastic and convert it into L-DOPA through a series of carefully designed chemical reactions. What used to sit in landfills or sink in the oceans can now help improve people’s lives.
“This is just the beginning,” said Professor Stephen Wallace, who led the research. “If we can create drugs for neurological diseases from a single waste plastic bottle, it’s exciting to imagine what else this technology can achieve.”
Wallace notes that while plastic is often viewed as an environmental threat, he identifies it as a significant opportunity. He explains that plastic waste is a vast and underutilized source of carbon. By turning this carbon into pharmaceuticals, the research redefines the value of the material and suggests that waste, rather than waste, can serve as an important resource for medical advances.
The project is funded by Research and Innovation UK and the Industrial Biotechnology Innovation Center (IBioIC) and forms part of a wider effort to reimagine waste in creative and useful ways.
Dr. Liz Fletcher, Deputy Chief Executive of IBioIC, stated that turning plastic bottles into Parkinson’s medicine represents more than just an innovative recycling concept. He explained that the initiative as a method of redesigning processes to adapt to nature rather than against it, and ultimately provide specific priorities.
Traditionally, pharmaceuticals rely on “virgin” fossil fuels and intensive petrochemical synthesis – essentially making medicine out of oil. This new approach replaces that carbon-heavy cycle with a bio-cycling process that is more sustainable and potentially less expensive. By replacing oil production with waste medicine, plastic that would otherwise be incinerated, thrown away or polluting the oceans now feeds the creation of life-saving medicines.
The technique also points to a broader vision in which biological systems can produce not only medicines, but also cosmetics, fragrances, fragrances and industrial chemicals, all while reducing environmental impact.
The team successfully demonstrated this process on a laboratory scale. The next step is industrialization. Optimization of efficiency, scale of production and assessment of environmental and economic impact.
Professor Charlotte Dean, Chief Executive of UKRI EPSRC, said: “This research is a great example of how biology can be developed to solve some of society’s most pressing problems.” “By turning discarded plastic into a treatment for Parkinson’s disease, the team is showing how carbon that would otherwise be lost can be turned into valuable products that improve lives.”
Longevity meets durability. Just as biotech research often tries to extend life by using existing drugs for new diseases, this development shows that we can extend the life of our planet by using our waste. By treating plastic not as a pollutant to be hidden, but as a molecular library to be used, we are creating a circular healthcare system where the cures for tomorrow’s diseases are literally found in yesterday’s waste.
By recycling plastics to treat neurological diseases, we are not only extending our lives; we are rethinking how our industries affect the world of our age. As the population grows and the climate crisis intensifies, solutions like these show that the future of medicine is closely linked to the future of the planet.
Wallace and his team emphasize that their work shows how waste can be reimagined as a resource for human health by using engineering biology to turn plastic into essential medicine. For the longevity community, it’s a reminder that extending life can also be about innovating responsibly, sustainably and creatively.
The main image shows Professor Stephen Wallace collecting engineered bacteria for analysis (credit: Edinburgh Innovations).
(1) https://www.ed.ac.uk/news/waste-plastic-turned-into-parkinsons-drug
